Next earnings date: 5 Nov 2025
Beximco Pharmaceuticals Limited – LSE:BXP.L
Beximco Pharmaceuticals Limited stock price today
Beximco Pharmaceuticals Limited stock price monthly change
Beximco Pharmaceuticals Limited stock price quarterly change
Beximco Pharmaceuticals Limited stock price yearly change
Beximco Pharmaceuticals Limited key metrics
Market Cap | 169.52M |
Enterprise value | 26.12B |
P/E | 4.17 |
EV/Sales | 0.58 |
EV/EBITDA | 2.69 |
Price/Sales | 0.55 |
Price/Book | 0.50 |
PEG ratio | 1.06 |
EPS | 11.95 |
Revenue | 43.08B |
EBITDA | 8.45B |
Income | 5.33B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 13.25% |
Oper. margin | 19.86% |
Gross margin | 44.8% |
EBIT margin | 19.86% |
EBITDA margin | 19.62% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBeximco Pharmaceuticals Limited stock price history
Beximco Pharmaceuticals Limited stock forecast
Beximco Pharmaceuticals Limited financial statements
| Jun 2023 | 10.03B | 979.47M | 9.76% |
|---|---|---|---|
| Sep 2023 | 11.15B | 1.55B | 13.92% |
| Dec 2023 | 10.90B | 1.43B | 13.15% |
| Mar 2024 | 10.98B | 1.36B | 12.42% |
| 2028 | 80.11B | 9.85B | 12.31% |
|---|
Analysts Price target
Financials & Ratios estimates
| Payout ratio | 26.64% |
|---|
| 2015 | 3.27% |
|---|---|
| 2017 | 0.75% |
| 2019 | 3.07% |
| 2020 | 3.97% |
| 2022 | 4.53% |
| Dec 2022 | 69314488000 | 23.59B | 34.03% |
|---|---|---|---|
| Sep 2023 | 69351576000 | 20.16B | 29.08% |
| Dec 2023 | 70626673000 | 21.58B | 30.56% |
| Mar 2024 | 70223294000 | 19.81B | 28.21% |
| Jun 2023 | 1.77B | -831.32M | -829.38M |
|---|---|---|---|
| Sep 2023 | 2.70B | -807.31M | -2.10B |
| Dec 2023 | 1.75B | -599.98M | -1.00B |
| Mar 2024 | 2.13B | -344.36M | -1.72B |
Beximco Pharmaceuticals Limited alternative data
| Aug 2023 | 5,500 |
|---|---|
| Sep 2023 | 5,500 |
| Oct 2023 | 5,500 |
| Nov 2023 | 5,500 |
| Dec 2023 | 5,500 |
| Jan 2024 | 5,500 |
| Feb 2024 | 5,700 |
| Mar 2024 | 5,700 |
| Apr 2024 | 5,700 |
| May 2024 | 5,700 |
| Jun 2024 | 5,500 |
| Jul 2024 | 5,500 |
Beximco Pharmaceuticals Limited other data
-
What's the price of Beximco Pharmaceuticals Limited stock today?
One share of Beximco Pharmaceuticals Limited stock can currently be purchased for approximately $121.5.
-
When is Beximco Pharmaceuticals Limited's next earnings date?
Beximco Pharmaceuticals Limited is estimated to report earnings on Wednesday, 5 Nov 2025.
-
Does Beximco Pharmaceuticals Limited pay dividends?
Yes, Beximco Pharmaceuticals Limited pays dividends and its trailing 12-month yield is 5.98% with 27% payout ratio. The last Beximco Pharmaceuticals Limited stock dividend of $4.08 was paid on 7 Sep 2025.
-
How much money does Beximco Pharmaceuticals Limited make?
Beximco Pharmaceuticals Limited has a market capitalization of 169.52M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 28.04% to 44.39B US dollars.
-
What is Beximco Pharmaceuticals Limited's stock symbol?
Beximco Pharmaceuticals Limited is traded on the LSE under the ticker symbol "BXP.L".
-
What is Beximco Pharmaceuticals Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Beximco Pharmaceuticals Limited?
Shares of Beximco Pharmaceuticals Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Beximco Pharmaceuticals Limited have?
As Jul 2024, Beximco Pharmaceuticals Limited employs 5,500 workers, which is 4% less then previous quarter.
-
When Beximco Pharmaceuticals Limited went public?
Beximco Pharmaceuticals Limited is publicly traded company for more then 19 years since IPO on 21 Oct 2005.
-
What is Beximco Pharmaceuticals Limited's official website?
The official website for Beximco Pharmaceuticals Limited is beximcopharma.com.
-
How can i contact Beximco Pharmaceuticals Limited?
Beximco Pharmaceuticals Limited can be reached via phone at +880 2 58611001.
Beximco Pharmaceuticals Limited company profile:
Beximco Pharmaceuticals Limited
beximcopharma.comLSE
1,122
Drug Manufacturers - Specialty & Generic
Healthcare
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Dhaka, 1205
:
ISIN: US0885792061
:
